| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Peyer James | Other | 12/09/2025 | DS | Indirect | COM | 446 | $7.92 | $3,532.32 | 155,142 |
| Peyer James | Other | 12/09/2025 | DS | Indirect | COM | 395 | $8.04 | $3,175.80 | 155,588 |
| Peyer James | Other | 12/09/2025 | AM | Indirect | COM | 395 | $6.40 | $2,528.00 | 155,983 |
| Peyer James | Other | 12/09/2025 | DS | Indirect | COM | 2,666 | $7.95 | $21,194.70 | 155,588 |
| Cambrian Biopharma Inc | Other | 12/09/2025 | DS | Direct | COM | 446 | $7.92 | $3,532.32 | 155,142 |
| Cambrian Biopharma Inc | Other | 12/09/2025 | DS | Direct | COM | 395 | $8.04 | $3,175.80 | 155,588 |
| Cambrian Biopharma Inc | Other | 12/09/2025 | AM | Direct | COM | 395 | $6.40 | $2,528.00 | 155,983 |
| Cambrian Biopharma Inc | Other | 12/09/2025 | DS | Direct | COM | 2,666 | $7.95 | $21,194.70 | 155,588 |
| Cambrian Biopharma Inc | Other | 12/09/2025 | DS | Direct | COM | 3,105 | $8.59 | $26,671.95 | 158,254 |
| Peyer James | Other | 12/08/2025 | DS | Indirect | COM | 3,105 | $8.59 | $26,671.95 | 158,254 |
| Peyer James | Other | 12/05/2025 | DS | Indirect | COM | 42 | $13.16 | $552.72 | 161,359 |
| Peyer James | Other | 12/05/2025 | DS | Indirect | COM | 1,745 | $12.29 | $21,446.05 | 161,401 |
| Peyer James | Other | 12/05/2025 | DS | Indirect | COM | 14,508 | $11.40 | $165,391.20 | 163,146 |
| Cambrian Biopharma Inc | Other | 12/05/2025 | DS | Direct | COM | 42 | $13.16 | $552.72 | 161,359 |
| Cambrian Biopharma Inc | Other | 12/05/2025 | DS | Direct | COM | 1,745 | $12.29 | $21,446.05 | 161,401 |
| Cambrian Biopharma Inc | Other | 12/05/2025 | DS | Direct | COM | 14,508 | $11.40 | $165,391.20 | 163,146 |
| Peyer James | Other | 12/04/2025 | DS | Indirect | COM | 5,000 | $9.06 | $45,300.00 | 177,654 |
| Cambrian Biopharma Inc | Other | 12/04/2025 | DS | Direct | COM | 5,000 | $9.06 | $45,300.00 | 177,654 |
| Van Der Horst Edward | CHIEF SCIENTIFIC OFFICER | 02/19/2025 | DF | Direct | COM | 2,276 | $0.48 | $1,083.38 | 59,794 |
| Celebi John | PRESIDENT AND CEO | 02/19/2025 | DF | Direct | COM | 5,558 | $0.48 | $2,645.61 | 105,862 |
| 1   You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
![]() |
Send to Excel | |||||||